{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:57:58Z","timestamp":1791493078866,"version":"4.3.4"},"reference-count":175,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The calcineurin inhibitors (CNIs) ciclosporin and tacrolimus are cornerstone immunosuppressants in solid organ transplantation, yet calcineurin blockade in endocrine tissues produces characteristic metabolic sequelae. This review synthesizes evidence on CNI-related disturbances in glucose and lipid metabolism, mineral balance, bone, and neuroendocrine axes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Calcineurin inhibitors precipitate post-transplant diabetes mellitus by blunting \u03b2-cell insulin release and augmenting insulin resistance; tacrolimus is consistently more diabetogenic than ciclosporin. Weight gain and atherogenic dyslipidemia are common. Both agents accelerate trabecular bone loss via osteoclast activation, significantly increasing early fracture risk. Calcineurin blockade downregulates TRPM6\/7 channels and aldosterone synthase, causing chronic hypomagnesemia, hyperkalemic type IV-like renal tubular acidosis, and fludrocortisone-responsive hypoaldosteronism. Adrenal insufficiency is uncommon but requires vigilance during acute illness or steroid withdrawal. Gonadal dysfunction is mild and reversible. Ciclosporin-associated hypertrichosis is well-established, and tacrolimus-induced alopecia was reported. Thyroid impact is negligible. Sleep disturbances can occur. A pragmatic monitoring algorithm integrating biochemical panels, bone densitometry, and stress-responsive adrenal testing enables early detection. Therapeutic strategies include magnesium repletion, early antiresorptive therapy, judicious CNI minimization, fludrocortisone for refractory hyperkalemia, and use of cardio-renal-protective antidiabetic agents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Because CNI-related endocrine toxicities are common yet modifiable, routine multidisciplinary endocrinology involvement should be standard transplant care. Prospective registry studies should validate these algorithms and quantify long-term benefits for graft and patient survival.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf182","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:58:39Z","timestamp":1757678319000},"page":"R1-R16","source":"Crossref","is-referenced-by-count":19,"title":["Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6211-2073","authenticated-orcid":false,"given":"Talia","family":"Diker Cohen","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center, Beilinson Hospital , 39 Jabotinski St., Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-4759","authenticated-orcid":false,"given":"Idit","family":"Dotan","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center, Beilinson Hospital , 39 Jabotinski St., Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5124-0748","authenticated-orcid":false,"given":"Bronya","family":"Calvarysky","sequence":"additional","affiliation":[{"name":"Pharmacy, Rabin Medical Center, Beilinson Hospital , Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Faculty of Medicine, The Hebrew University of Jerusalem , Jerusalem 9112102 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6268-4212","authenticated-orcid":false,"given":"Eyal","family":"Robenshtok","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center, Beilinson Hospital , 39 Jabotinski St., Petah Tikva 4941492 ,","place":["Israel"]},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv 6997801 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"issue":"2","key":"2025092123520898500_lvaf182-B1","doi-asserted-by":"publisher","first-page":"25S","DOI":"10.1016\/j.transproceed.2004.01.018","article-title":"Pharmacology of calcineurin antagonists","volume":"36","author":"Kapturczak","year":"2004","journal-title":"Transplant Proc"},{"issue":"25","key":"2025092123520898500_lvaf182-B2","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"2025092123520898500_lvaf182-B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/164_2021_549","article-title":"A comprehensive review of calcineurin inhibitors used for immunosuppression in cardiac transplantation","volume":"272","author":"Engwenyu","year":"2022","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"2025092123520898500_lvaf182-B4","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00228-024-03750-1","article-title":"Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials","volume":"80","author":"Suilik","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"issue":"7520","key":"2025092123520898500_lvaf182-B5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"Bmj"},{"issue":"1","key":"2025092123520898500_lvaf182-B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"2025092123520898500_lvaf182-B7","doi-asserted-by":"publisher","first-page":"F336","DOI":"10.1152\/ajprenal.00262.2020","article-title":"Calcineurin inhibitors: a double-edged sword","volume":"320","author":"Ume","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"2025092123520898500_lvaf182-B8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/FPC.0b013e328364db84","article-title":"PharmGKB summary: cyclosporine and tacrolimus pathways","volume":"23","author":"Barbarino","year":"2013","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"2025092123520898500_lvaf182-B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes","volume":"37","author":"Shivaswamy","year":"2016","journal-title":"Endocr Rev"},{"issue":"4","key":"2025092123520898500_lvaf182-B10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s2213-8587(15)00387-3","article-title":"Post-transplantation diabetes-state of the art","volume":"4","author":"Sharif","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025092123520898500_lvaf182-B11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ndt\/gfad258","article-title":"International consensus on post-transplantation diabetes mellitus","volume":"39","author":"Sharif","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2025092123520898500_lvaf182-B12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/ndt\/gfae185","article-title":"Prognostic impact of post-transplant diabetes mellitus in kidney allograft recipients: a meta-analysis","volume":"40","author":"Kanbay","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2025092123520898500_lvaf182-B13","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/ajt.12236","article-title":"The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats","volume":"13","author":"Rodriguez-Rodriguez","year":"2013","journal-title":"Am J Transplant"},{"issue":"7","key":"2025092123520898500_lvaf182-B14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00228-021-03095-z","article-title":"Calcineurin inhibitor-associated new-onset diabetes mellitus in chronic kidney disease treatment: a 4-year single-center cross-sectional study in China","volume":"77","author":"Kun-Ming","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2025092123520898500_lvaf182-B15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2215\/CJN.00620206","article-title":"Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes","volume":"2","author":"Burroughs","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2025092123520898500_lvaf182-B16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2025092123520898500_lvaf182-B17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1476-5381.2010.01018.x","article-title":"Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells","volume":"162","author":"Ozbay","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"11","key":"2025092123520898500_lvaf182-B18","doi-asserted-by":"publisher","first-page":"bqaa162","DOI":"10.1210\/endocr\/bqaa162","article-title":"Differential effects of voclosporin and tacrolimus on insulin secretion from human islets","volume":"161","author":"Kolic","year":"2020","journal-title":"Endocrinology"},{"issue":"10","key":"2025092123520898500_lvaf182-B19","doi-asserted-by":"publisher","first-page":"E1885","DOI":"10.1210\/jc.2014-1266","article-title":"Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents","volume":"99","author":"Pereira","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025092123520898500_lvaf182-B20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/TP.0b013e31826e592e","article-title":"Calcineurin inhibition and new-onset diabetes mellitus after transplantation","volume":"95","author":"Chakkera","year":"2013","journal-title":"Transplantation"},{"issue":"12","key":"2025092123520898500_lvaf182-B21","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1111\/dme.12028","article-title":"The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients","volume":"29","author":"Ozbay","year":"2012","journal-title":"Diabet Med"},{"issue":"11","key":"2025092123520898500_lvaf182-B22","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/ajt.14323","article-title":"Deciphering tacrolimus-induced toxicity in pancreatic beta cells","volume":"17","author":"Trinanes","year":"2017","journal-title":"Am J Transplant"},{"issue":"11","key":"2025092123520898500_lvaf182-B23","doi-asserted-by":"publisher","first-page":"e0160421","DOI":"10.1371\/journal.pone.0160421","article-title":"Systematic review and meta-analysis of tacrolimus versus ciclosporin as primary immunosuppression after liver transplant","volume":"11","author":"Muduma","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"2025092123520898500_lvaf182-B24","doi-asserted-by":"publisher","first-page":"CD008817","DOI":"10.1002\/14651858.CD008817.pub2","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients","volume":"2013","author":"Penninga","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2025092123520898500_lvaf182-B25","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"issue":"2","key":"2025092123520898500_lvaf182-B26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1432-2277.2007.00589.x","article-title":"Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature","volume":"21","author":"Ghisdal","year":"2008","journal-title":"Transpl Int"},{"issue":"7","key":"2025092123520898500_lvaf182-B27","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/ajt.14665","article-title":"Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation","volume":"18","author":"Wissing","year":"2018","journal-title":"Am J Transplant"},{"issue":"8","key":"2025092123520898500_lvaf182-B28","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1681\/asn.2021010127","article-title":"Early postoperative basal insulin therapy versus standard of care for the prevention of diabetes mellitus after kidney transplantation: a multicenter randomized trial","volume":"32","author":"Schwaiger","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2025092123520898500_lvaf182-B29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1681\/asn.2011080835","article-title":"Early basal insulin therapy decreases new-onset diabetes after renal transplantation","volume":"23","author":"Hecking","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2025092123520898500_lvaf182-B30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.trre.2016.09.001","article-title":"Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus","volume":"31","author":"Vanhove","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"issue":"4","key":"2025092123520898500_lvaf182-B31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.clpt.2005.07.005","article-title":"Cyclosporine markedly raises the plasma concentrations of repaglinide","volume":"78","author":"Kajosaari","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2025092123520898500_lvaf182-B32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/2042018816638050","article-title":"Clinically and pharmacologically relevant interactions of antidiabetic drugs","volume":"7","author":"May","year":"2016","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"4","key":"2025092123520898500_lvaf182-B33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01250.x","article-title":"Repaglinide in the management of new-onset diabetes mellitus after renal transplantation","volume":"6","author":"T\u00fcrk","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"2025092123520898500_lvaf182-B34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/0091270006296523","article-title":"Effect of a single cyclosporine dose on the single-dose pharmacokinetics of sitagliptin (MK-0431), a dipeptidyl peptidase-4 inhibitor, in healthy male subjects","volume":"47","author":"Krishna","year":"2007","journal-title":"J Clin Pharmacol"},{"issue":"(02|2)","key":"2025092123520898500_lvaf182-B35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5414\/cp202158","article-title":"Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants","volume":"53","author":"Devineni","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"2025092123520898500_lvaf182-B36","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/00007691-199610000-00017","article-title":"Possible interaction between cyclosporine and glibenclamide in posttransplant diabetic patients","volume":"18","author":"Islam","year":"1996","journal-title":"Ther Drug Monit"},{"issue":"1","key":"2025092123520898500_lvaf182-B37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3803\/EnM.2016.31.1.161","article-title":"Effects of dipeptidyl peptidase-4 inhibitors on hyperglycemia and blood cyclosporine levels in renal transplant patients with diabetes: a pilot study","volume":"31","author":"Bae","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"10","key":"2025092123520898500_lvaf182-B38","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.2337\/dc13-1066","article-title":"Coadministration of liraglutide with tacrolimus in kidney transplant recipients: a case series","volume":"36","author":"Pinelli","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"2025092123520898500_lvaf182-B39","doi-asserted-by":"publisher","first-page":"sfae018","DOI":"10.1093\/ckj\/sfae018","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis","volume":"17","author":"Krisanapan","year":"2024","journal-title":"Clin Kidney J"},{"issue":"4","key":"2025092123520898500_lvaf182-B40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s13300-020-00786-1","article-title":"A retrospective study of glucagon-like peptide 1 receptor agonists for the management of diabetes after transplantation","volume":"11","author":"Thangavelu","year":"2020","journal-title":"Diabetes Ther"},{"issue":"4","key":"2025092123520898500_lvaf182-B41","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/ijn.IJN_2_18","article-title":"Efficacy and safety of canagliflozin in kidney transplant patients","volume":"29","author":"Shah","year":"2019","journal-title":"Indian J Nephrol"},{"issue":"10","key":"2025092123520898500_lvaf182-B42","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2165\/00002018-200124100-00004","article-title":"Calcineurin inhibitors and post-transplant hyperlipidaemias","volume":"24","author":"Moore","year":"2001","journal-title":"Drug Saf"},{"issue":"2","key":"2025092123520898500_lvaf182-B43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12291-012-0251-6","article-title":"Lipid parameters, doses and blood levels of calcineurin inhibitors in renal transplant patients","volume":"28","author":"Ciftci","year":"2013","journal-title":"Indian J Clin Biochem"},{"issue":"12","key":"2025092123520898500_lvaf182-B44","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00228-010-0902-6","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials","volume":"66","author":"Penninga","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2025092123520898500_lvaf182-B45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/00007890-199409000-00006","article-title":"The effect of FK506 versus cyclosporine on glucose and lipid metabolism\u2013a randomized trial","volume":"58","author":"Steinm\u00fcller","year":"1994","journal-title":"Transplantation"},{"key":"2025092123520898500_lvaf182-B46","doi-asserted-by":"publisher","first-page":"981838","DOI":"10.3389\/fcvm.2022.981838","article-title":"Cardiovascular effects of immunosuppression agents","volume":"9","author":"Elezaby","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"2025092123520898500_lvaf182-B47","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1016\/j.transproceed.2005.10.068","article-title":"Effect of calcineurin inhibitors on low-density lipoprotein oxidation","volume":"37","author":"Cofan","year":"2005","journal-title":"Transplant Proc"},{"issue":"1","key":"2025092123520898500_lvaf182-B48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00007890-199801150-00017","article-title":"Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a southeastern organ procurement foundation multicenter clinical study","volume":"65","author":"McCune","year":"1998","journal-title":"Transplantation"},{"issue":"5","key":"2025092123520898500_lvaf182-B49","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1074\/jbc.M112.419150","article-title":"Ablation of calcineurin A\u03b2 reveals hyperlipidemia and signaling cross-talks with phosphodiesterases","volume":"288","author":"Suk","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"2025092123520898500_lvaf182-B50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/hep.510240325","article-title":"Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%","volume":"24","author":"Rayyes","year":"1996","journal-title":"Hepatology"},{"issue":"21","key":"2025092123520898500_lvaf182-B51","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/cir.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"issue":"Suppl 7","key":"2025092123520898500_lvaf182-B52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1600-6135.2004.0355.x","article-title":"Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the managing dyslipidemias in chronic kidney disease work group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"issue":"5","key":"2025092123520898500_lvaf182-B53","doi-asserted-by":"publisher","first-page":"e1S","DOI":"10.1378\/chest.12-1044","article-title":"Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"142","author":"Baughman","year":"2012","journal-title":"Chest"},{"issue":"2","key":"2025092123520898500_lvaf182-B54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/endrev\/bnaa030","article-title":"Metabolic consequences of solid organ transplantation","volume":"42","author":"Bhat","year":"2021","journal-title":"Endocr Rev"},{"issue":"5","key":"2025092123520898500_lvaf182-B55","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.nefroe.2021.08.009","article-title":"Effect of weight change after renal transplantation on outcomes of graft survival","volume":"42","author":"Barroso Hern\u00e1ndez","year":"2022","journal-title":"Nefrologia (Engl Ed)"},{"issue":"2","key":"2025092123520898500_lvaf182-B56","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/ndt\/gfac169","article-title":"Retrospective analysis of the impact of severe obesity on kidney transplant outcomes","volume":"38","author":"Tsapepas","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2025092123520898500_lvaf182-B57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-0012.2008.00792.x","article-title":"Obesity following kidney transplantation and steroid avoidance immunosuppression","volume":"22","author":"Elster","year":"2008","journal-title":"Clin Transplant"},{"issue":"5","key":"2025092123520898500_lvaf182-B58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1440-1797.2008.00916.x","article-title":"Calcineurin inhibitors and post-transplant weight gain","volume":"13","author":"Ersoy","year":"2008","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"2025092123520898500_lvaf182-B59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1053\/j.jrn.2016.02.007","article-title":"Association of abdominal circumference, body mass index, and inflammation in kidney transplant recipients","volume":"26","author":"Nagy","year":"2016","journal-title":"J Ren Nutr"},{"issue":"1","key":"2025092123520898500_lvaf182-B60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12882-022-03004-1","article-title":"The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients","volume":"23","author":"Sayilar","year":"2022","journal-title":"BMC Nephrol"},{"issue":"1","key":"2025092123520898500_lvaf182-B61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.transproceed.2014.11.025","article-title":"Incidence of development of obesity after heart transplantation according to the calcineurin inhibitor","volume":"47","author":"L\u00f3pez-Vilella","year":"2015","journal-title":"Transplant Proc"},{"issue":"4","key":"2025092123520898500_lvaf182-B62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/lt.500040402","article-title":"Weight change and obesity after liver transplantation: incidence and risk factors","volume":"4","author":"Everhart","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"4","key":"2025092123520898500_lvaf182-B63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1432-2277.2004.00067.x","article-title":"Weight gain and obesity after liver transplantation","volume":"18","author":"Richards","year":"2005","journal-title":"Transpl Int"},{"issue":"4","key":"2025092123520898500_lvaf182-B64","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3305\/nh.2012.27.4.5768","article-title":"Overweight, obesity and weight gain up to three years after liver transplantation","volume":"27","author":"Rezende Anast\u00e1cio","year":"2012","journal-title":"Nutr Hosp"},{"issue":"12","key":"2025092123520898500_lvaf182-B65","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1097\/tp.0000000000001913","article-title":"Everolimus is associated with less weight gain than tacrolimus 2 years after liver transplantation: results of a randomized multicenter study","volume":"101","author":"Charlton","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"2025092123520898500_lvaf182-B66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12016-025-09046-1","article-title":"Osteoimmunology: crosstalk between T cells and osteoclasts in osteoporosis","volume":"68","author":"Lu","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"2025092123520898500_lvaf182-B67","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3803\/EnM.2024.1939","article-title":"Bone loss after solid organ transplantation: a review of organ-specific considerations","volume":"39","author":"Kim","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2025092123520898500_lvaf182-B68","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bone.2019.07.006","article-title":"Bone disease following solid organ transplantation: a narrative review and recommendations for management from the European Calcified Tissue Society","volume":"127","author":"Anastasilakis","year":"2019","journal-title":"Bone"},{"issue":"12","key":"2025092123520898500_lvaf182-B69","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1359\/jbmr.2003.18.12.2083","article-title":"Disorders associated with acute rapid and severe bone loss","volume":"18","author":"Epstein","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025092123520898500_lvaf182-B70","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2362.1996.00170.x","article-title":"Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation","volume":"26","author":"Thiebaud","year":"1996","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"2025092123520898500_lvaf182-B71","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1210\/endo.137.6.8641176","article-title":"T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia","volume":"137","author":"Buchinsky","year":"1996","journal-title":"Endocrinology"},{"issue":"2","key":"2025092123520898500_lvaf182-B72","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bbrc.2012.09.077","article-title":"Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation","volume":"427","author":"Zawawi","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2025092123520898500_lvaf182-B73","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1210\/endo-123-5-2571","article-title":"Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration","volume":"123","author":"Movsowitz","year":"1988","journal-title":"Endocrinology"},{"issue":"5","key":"2025092123520898500_lvaf182-B74","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1759720X14546350","article-title":"Medication-induced osteoporosis: screening and treatment strategies","volume":"6","author":"Panday","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"47","key":"2025092123520898500_lvaf182-B75","doi-asserted-by":"publisher","first-page":"17130","DOI":"10.1073\/pnas.0508480102","article-title":"Calcineurin regulates bone formation by the osteoblast","volume":"102","author":"Sun","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2025092123520898500_lvaf182-B76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/jbmr.5650040314","article-title":"Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption","volume":"4","author":"Movsowitz","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025092123520898500_lvaf182-B77","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2220\/biomedres.39.131","article-title":"Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats","volume":"39","author":"Kanda","year":"2018","journal-title":"Biomed Res"},{"issue":"10","key":"2025092123520898500_lvaf182-B78","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"2025092123520898500_lvaf182-B79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000328874","article-title":"Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism","volume":"34","author":"Lee","year":"2011","journal-title":"Am J Nephrol"},{"issue":"3","key":"2025092123520898500_lvaf182-B80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trre.2015.05.002","article-title":"Hypomagnesaemia in kidney transplantation","volume":"29","author":"Van Laecke","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"issue":"4","key":"2025092123520898500_lvaf182-B81","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00007890-200202270-00010","article-title":"The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol","volume":"73","author":"Stempfle","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"2025092123520898500_lvaf182-B82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s001470000285","article-title":"Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation","volume":"14","author":"Grotz","year":"2001","journal-title":"Transpl Int"},{"issue":"8","key":"2025092123520898500_lvaf182-B83","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/01.tp.0000137937.44703.42","article-title":"Calcium and calcitriol prophylaxis attenuates posttransplant bone loss","volume":"78","author":"Josephson","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"2025092123520898500_lvaf182-B84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF02678145","article-title":"Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A","volume":"68","author":"Monegal","year":"2001","journal-title":"Calcif Tissue Int"},{"issue":"Supp 4","key":"2025092123520898500_lvaf182-B85","first-page":"S15","article-title":"A randomised controlled trial of the effects of ciclosporin versus tacrolimus on bone mineral density in renal transplant recipients","volume":"14","author":"Wareham","year":"2003","journal-title":"Osteoporosis International"},{"issue":"1","key":"2025092123520898500_lvaf182-B86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1399-0012.1995.tb00291.x","article-title":"Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens","volume":"9","author":"McIntyre","year":"1995","journal-title":"Clin Transplant"},{"issue":"2296-858X (Print)","key":"2025092123520898500_lvaf182-B87","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fmed.2018.00261","article-title":"Electrolyte and acid-base disorders in the renal transplant recipient","volume":"5","author":"Pochineni","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"21","key":"2025092123520898500_lvaf182-B88","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMra1510603","article-title":"Magnesium disorders","volume":"390","author":"Touyz","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"2025092123520898500_lvaf182-B89","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/TP.0b013e31817fe069","article-title":"Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice","volume":"86","author":"Sabbagh","year":"2008","journal-title":"Transplantation"},{"issue":"5","key":"2025092123520898500_lvaf182-B90","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.transproceed.2006.02.077","article-title":"Tacrolimus-associated hypomagnesemia in renal transplant recipients","volume":"38","author":"Navaneethan","year":"2006","journal-title":"Transplant Proc"},{"issue":"6","key":"2025092123520898500_lvaf182-B91","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/nu10060677","article-title":"Longitudinal study of the role of epidermal growth factor on the fractional excretion of magnesium in children: effect of calcineurin inhibitors","volume":"10","author":"Ledeganck","year":"2018","journal-title":"Nutrients"},{"issue":"8","key":"2025092123520898500_lvaf182-B92","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/01.tp.0000174340.40585.d4","article-title":"Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation","volume":"80","author":"Aisa","year":"2005","journal-title":"Transplantation"},{"issue":"8","key":"2025092123520898500_lvaf182-B93","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1016\/j.transproceed.2010.08.016","article-title":"Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes","volume":"42","author":"Osorio","year":"2010","journal-title":"Transplant Proc"},{"key":"2025092123520898500_lvaf182-B94","doi-asserted-by":"publisher","first-page":"616719","DOI":"10.3389\/fphar.2021.616719","article-title":"Proton pump inhibitor and tacrolimus uses are associated with hypomagnesemia in connective tissue disease: a potential link with renal dysfunction and recurrent infection","volume":"12","author":"Hanaoka","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"2025092123520898500_lvaf182-B95","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/nu10060729","article-title":"Serum magnesium after kidney transplantation: a systematic review","volume":"10","author":"Garnier","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"2025092123520898500_lvaf182-B96","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1681\/asn.2015040391","article-title":"Hypomagnesemia and the risk of new-onset diabetes mellitus after kidney transplantation","volume":"27","author":"Huang","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2025092123520898500_lvaf182-B97","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/nu17010050","article-title":"The impact of hypomagnesemia on the long-term evolution after kidney transplantation","volume":"17","author":"Ratiu","year":"2024","journal-title":"Nutrients"},{"issue":"7","key":"2025092123520898500_lvaf182-B98","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/ndt\/gfh831","article-title":"Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity","volume":"20","author":"Holzmacher","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2025092123520898500_lvaf182-B99","first-page":"47","article-title":"Magnesium metabolism and its disorders","volume":"24","author":"Swaminathan","year":"2003","journal-title":"Clin Biochem Rev"},{"issue":"1","key":"2025092123520898500_lvaf182-B100","first-page":"58","article-title":"Hypomagnesemia: renal magnesium handling","volume":"18","author":"Kelepouris","year":"1998","journal-title":"Semin Nephrol"},{"issue":"1","key":"2025092123520898500_lvaf182-B101","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.transproceed.2003.11.017","article-title":"Effects of different calcineurin inhibitors on sex hormone levels in transplanted male patients","volume":"36","author":"Kantarci","year":"2004","journal-title":"Transplant Proc"},{"issue":"6","key":"2025092123520898500_lvaf182-B102","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/00007890-198812000-00019","article-title":"Effect of cyclosporine on steroidogenesis in rat Leydig cells","volume":"46","author":"Sikka","year":"1988","journal-title":"Transplantation"},{"issue":"1","key":"2025092123520898500_lvaf182-B103","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00007890-199201000-00037","article-title":"The mechanism of cyclosporine's action in the inhibition of testosterone biosynthesis by rat Leydig cells in vitro","volume":"53","author":"Seethalakshmi","year":"1992","journal-title":"Transplantation"},{"issue":"5","key":"2025092123520898500_lvaf182-B104","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/and.12477","article-title":"Calcineurin inhibitors and male fertility after renal transplantation\u2014a review","volume":"48","author":"Georgiou","year":"2016","journal-title":"Andrologia"},{"issue":"4","key":"2025092123520898500_lvaf182-B105","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/j.1939-4640.1992.tb00330.x","article-title":"Changes in the hypothalamic-pituitary-gonadal axis in men after cadaver kidney transplantation and cyclosporine therapy","volume":"13","author":"Samojlik","year":"1992","journal-title":"J Androl"},{"key":"2025092123520898500_lvaf182-B106","doi-asserted-by":"publisher","first-page":"690382","DOI":"10.1155\/2013\/690382","article-title":"Long-term impact of immunosuppressants at therapeutic doses on male reproductive system in unilateral nephrectomized rats: a comparative study","volume":"2013","author":"Chen","year":"2013","journal-title":"Biomed Res Int"},{"issue":"6259","key":"2025092123520898500_lvaf182-B107","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1126\/science.aad0836","article-title":"Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive","volume":"350","author":"Miyata","year":"2015","journal-title":"Science"},{"key":"2025092123520898500_lvaf182-B108","doi-asserted-by":"publisher","first-page":"116374","DOI":"10.1016\/j.taap.2023.116374","article-title":"Low dose of cyclosporine A disrupts sperm parameters and testosterone levels reversibly in mice","volume":"460","author":"Siervo","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"2025092123520898500_lvaf182-B109","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12882-020-02115-x","article-title":"Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study","volume":"21","author":"Boyer","year":"2020","journal-title":"BMC Nephrol"},{"issue":"3","key":"2025092123520898500_lvaf182-B110","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1439-0272.2010.01052.x","article-title":"Characteristics of male fertility after renal transplantation","volume":"43","author":"Xu","year":"2011","journal-title":"Andrologia"},{"issue":"6","key":"2025092123520898500_lvaf182-B111","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/humupd\/dmaa022","article-title":"The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review","volume":"26","author":"Perez-Garcia","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"Supplement 1","key":"2025092123520898500_lvaf182-B112","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1097\/01.tp.0000231505.91988.26","article-title":"Drugs modulating endothelial function after transplantation","volume":"82","author":"Nickel","year":"2006","journal-title":"Transplantation"},{"issue":"6","key":"2025092123520898500_lvaf182-B113","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/jcm9061991","article-title":"Erectile dysfunction after kidney transplantation","volume":"9","author":"Perri","year":"2020","journal-title":"J Clin Med"},{"issue":"9","key":"2025092123520898500_lvaf182-B114","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/00029330-200805010-00009","article-title":"Prevalence and influential factors of erectile dysfunction in male renal transplant recipients: a multiple center survey","volume":"121","author":"Tian","year":"2008","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2025092123520898500_lvaf182-B115","doi-asserted-by":"publisher","first-page":"e38088","DOI":"10.7759\/cureus.38088","article-title":"Clinical implications and risk factors for erectile dysfunction in kidney transplant: a single-center assessment","volume":"15","author":"Miron","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"2025092123520898500_lvaf182-B116","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.ijir.3901056","article-title":"Factors associated with erectile dysfunction in male kidney transplant recipients","volume":"15","author":"Rebollo","year":"2003","journal-title":"Int J Impot Res"},{"issue":"7","key":"2025092123520898500_lvaf182-B117","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2165\/00003495-200767070-00003","article-title":"Treating erectile dysfunction in renal transplant recipients","volume":"67","author":"Barry","year":"2007","journal-title":"Drugs"},{"issue":"4","key":"2025092123520898500_lvaf182-B118","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/s0090-4295(01)01306-1","article-title":"Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation","volume":"58","author":"Christ","year":"2001","journal-title":"Urology"},{"issue":"5","key":"2025092123520898500_lvaf182-B119","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.transproceed.2006.02.076","article-title":"Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction","volume":"38","author":"Demir","year":"2006","journal-title":"Transplant Proc"},{"issue":"6","key":"2025092123520898500_lvaf182-B120","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.transproceed.2005.06.019","article-title":"Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients","volume":"37","author":"Iaria","year":"2005","journal-title":"Transplant Proc"},{"issue":"5","key":"2025092123520898500_lvaf182-B121","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00228-015-1835-x","article-title":"Gynecomastia and drugs: a critical evaluation of the literature","volume":"71","author":"Nuttall","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2025092123520898500_lvaf182-B122","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3265\/Nefrologia.pre2013.Aug.11891","article-title":"Painful gynaecomastia secondary to cyclosporine A and tacrolimus in a patient with focal segmental glomerulosclerosis","volume":"33","author":"Borrego-Utiel","year":"2013","journal-title":"Nefrologia (Engl Ed)."},{"issue":"5","key":"2025092123520898500_lvaf182-B123","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1248\/bpb.26.695","article-title":"Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17","volume":"26","author":"Satoh","year":"2003","journal-title":"Biol Pharm Bull"},{"issue":"11","key":"2025092123520898500_lvaf182-B124","doi-asserted-by":"publisher","first-page":"e6334","DOI":"10.1097\/gox.0000000000006334","article-title":"Successful surgical management of grade 4 gynecomastia in a renal transplant recipient","volume":"12","author":"Alabdulkarim","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"12","key":"2025092123520898500_lvaf182-B125","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/TP.0b013e31821c1e8b","article-title":"Tacrolimus and sirolimus induce reproductive abnormalities in female rats","volume":"91","author":"Shivaswamy","year":"2011","journal-title":"Transplantation"},{"issue":"2","key":"2025092123520898500_lvaf182-B126","doi-asserted-by":"publisher","first-page":"hoab012","DOI":"10.1093\/hropen\/hoab012","article-title":"Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model","volume":"2021","author":"Zakerkish","year":"2021","journal-title":"Hum Reprod Open"},{"issue":"4","key":"2025092123520898500_lvaf182-B127","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biology10040271","article-title":"Hormonal (im)balance and reproductive system's disorders in transplant recipients\u2014a review","volume":"10","author":"Szypulska-Koziarska","year":"2021","journal-title":"Biology (Basel)"},{"issue":"3","key":"2025092123520898500_lvaf182-B128","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.transproceed.2022.02.003","article-title":"Does tacrolimus use have a sexual dysfunctional effect in women after renal transplant?","volume":"54","author":"\u00d6nal","year":"2022","journal-title":"Transplant Proc"},{"issue":"10","key":"2025092123520898500_lvaf182-B129","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/ndt\/gfw289","article-title":"Pro: the use of calcineurin inhibitors in the treatment of lupus nephritis","volume":"31","author":"Mok","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2025092123520898500_lvaf182-B130","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2023.12.039","article-title":"Calcineurin inhibitors in the treatment of systemic lupus erythematosus during pregnancy: a narrative review with emphasis on efficacy and safety","volume":"294","author":"Jiang","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"2025092123520898500_lvaf182-B131","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1007\/s10067-017-3797-0","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve in systemic lupus erythematosus","volume":"36","author":"Martins","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025092123520898500_lvaf182-B132","doi-asserted-by":"publisher","first-page":"104157","DOI":"10.1016\/j.jri.2023.104157","article-title":"Calcineurin inhibitors in the management of recurrent miscarriage and recurrent implantation failure: systematic review and meta-analysis","volume":"160","author":"Cavalcante","year":"2023","journal-title":"J Reprod Immunol"},{"issue":"3","key":"2025092123520898500_lvaf182-B133","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.abd.2019.08.027","article-title":"Cyclosporine-induced childhood generalized hypertrichosis","volume":"95","author":"Souza","year":"2020","journal-title":"An Bras Dermatol"},{"issue":"9308","key":"2025092123520898500_lvaf182-B134","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"European tacrolimus vs ciclosporin microemulsion renal transplantation study G. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"2025092123520898500_lvaf182-B135","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00007890-198702000-00007","article-title":"Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years","volume":"43","author":"Kahan","year":"1987","journal-title":"Transplantation"},{"issue":"3","key":"2025092123520898500_lvaf182-B136","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000185158","article-title":"Ciclosporin-associated hypertrichosis is not related to sex hormone levels following renal transplantation","volume":"50","author":"Lindholm","year":"1988","journal-title":"Nephron"},{"issue":"(05|5)","key":"2025092123520898500_lvaf182-B137","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/s-0029-1210598","article-title":"Does cyclosporin A influence sex hormone level?","volume":"88","author":"Schmidt","year":"1986","journal-title":"Exp Clin Endocrinol"},{"issue":"8","key":"2025092123520898500_lvaf182-B138","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/jid.2015.121","article-title":"Re-evaluating cyclosporine A as a hair growth-promoting agent in human scalp hair follicles","volume":"135","author":"Hawkshaw","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2025092123520898500_lvaf182-B139","doi-asserted-by":"publisher","first-page":"C1593","DOI":"10.1152\/ajpcell.00537.2002","article-title":"Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes","volume":"284","author":"Gafter-Gvili","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"15","key":"2025092123520898500_lvaf182-B140","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2165\/00003495-200363150-00002","article-title":"Calcineurin inhibitors in renal transplantation: what is the best option?","volume":"63","author":"Tanabe","year":"2003","journal-title":"Drugs"},{"issue":"17","key":"2025092123520898500_lvaf182-B141","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation","volume":"331","author":"Group USMFLS","year":"1994","journal-title":"N Engl J Med"},{"issue":"11","key":"2025092123520898500_lvaf182-B142","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1111\/ajt.14337","article-title":"Cutaneous toxicities from transplantation-related medications","volume":"17","author":"Ilyas","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"2025092123520898500_lvaf182-B143","first-page":"35","article-title":"The side effects of FK 506 in humans","volume":"22","author":"Shapiro","year":"1990","journal-title":"Transplant Proc"},{"issue":"11","key":"2025092123520898500_lvaf182-B144","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1097\/01.tp.0000181195.67084.94","article-title":"Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients","volume":"80","author":"Tricot","year":"2005","journal-title":"Transplantation"},{"issue":"10","key":"2025092123520898500_lvaf182-B145","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc08-2339","article-title":"Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic islet cell recipients with pretransplant TPO autoantibodies","volume":"32","author":"Gillard","year":"2009","journal-title":"Diabetes Care"},{"issue":"12","key":"2025092123520898500_lvaf182-B146","doi-asserted-by":"publisher","first-page":"luae211","DOI":"10.1210\/jcemcr\/luae211","article-title":"Development of chronic thyroiditis during cyclosporin A treatment","volume":"2","author":"Hataya","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"2","key":"2025092123520898500_lvaf182-B147","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.0954-6820.1986.tb02749.x","article-title":"Treatment of Graves\u2019 ophthalmopathy with cyclosporin A","volume":"220","author":"Kvetny","year":"1986","journal-title":"Acta Med Scand"},{"issue":"3 Suppl 4","key":"2025092123520898500_lvaf182-B148","first-page":"173","article-title":"Immunosuppressive treatment of Graves\u2019 ophthalmopathy with cyclosporine A","volume":"20","author":"Utech","year":"1988","journal-title":"Transplant Proc"},{"issue":"1-2","key":"2025092123520898500_lvaf182-B149","first-page":"9","article-title":"Combined therapy with cyclosporin A and cortisone in endocrine Basedow endocrine orbitopathy: successful use in compressive optic neuropathy","volume":"20","author":"Weissel","year":"1993","journal-title":"Acta Med Austriaca"},{"issue":"10","key":"2025092123520898500_lvaf182-B150","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/sj.eye.6702393","article-title":"Avoiding surgery for thyroid eye disease","volume":"20","author":"Meyer","year":"2006","journal-title":"Eye (Lond)"},{"issue":"5","key":"2025092123520898500_lvaf182-B151","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/FTD.0b013e3181858169","article-title":"Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes","volume":"30","author":"Park","year":"2008","journal-title":"Ther Drug Monit"},{"issue":"4","key":"2025092123520898500_lvaf182-B152","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1248\/bpb.b24-00875","article-title":"Effects of calcineurin inhibitors on intestinal barrier in Caco-2 cells","volume":"48","author":"Suzuki","year":"2025","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"2025092123520898500_lvaf182-B153","doi-asserted-by":"publisher","first-page":"e14778","DOI":"10.1111\/petr.14778","article-title":"Calcineurin inhibitor-related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: report of a case series and review of the literature","volume":"28","author":"Unsal","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"2","key":"2025092123520898500_lvaf182-B154","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ndt\/gfg515","article-title":"Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities","volume":"19","author":"Higgins","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2025092123520898500_lvaf182-B155","doi-asserted-by":"publisher","first-page":"310","DOI":"10.14744\/semb.2017.75436","article-title":"Aldosterone resistance due to tacrolimus: a case report","volume":"52","author":"\u00c7a\u011flayan","year":"2018","journal-title":"Sisli Etfal Hastan Tip Bul"},{"issue":"12","key":"2025092123520898500_lvaf182-B156","doi-asserted-by":"publisher","first-page":"e14248","DOI":"10.1111\/apha.14248","article-title":"Calcineurin inhibitors and the renin-angiotensin-aldosterone system","volume":"240","author":"Berber","year":"2024","journal-title":"Acta Physiol (Oxf)"},{"issue":"14","key":"2025092123520898500_lvaf182-B157","doi-asserted-by":"publisher","first-page":"e157027","DOI":"10.1172\/jci.insight.157027","article-title":"Calcineurin regulates aldosterone production via dephosphorylation of NFATC4","volume":"8","author":"Berber","year":"2023","journal-title":"JCI Insight"},{"issue":"10","key":"2025092123520898500_lvaf182-B158","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"2025092123520898500_lvaf182-B159","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/jcpt.12485","article-title":"Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients","volume":"42","author":"Lin","year":"2017","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"2025092123520898500_lvaf182-B160","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0165-5728(92)90072-s","article-title":"Effects of cyclosporine A on the hypothalamic-pituitary-adrenal axis and anterior pituitary interleukin-6 mRNA expression during chronic inflammatory stress in the rat","volume":"41","author":"Stephanou","year":"1992","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2025092123520898500_lvaf182-B161","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0022-4804(92)90061-4","article-title":"Effect of cyclosporine on adrenocortical response to injury and infection","volume":"53","author":"Kapur","year":"1992","journal-title":"J Surg Res"},{"issue":"1","key":"2025092123520898500_lvaf182-B162","first-page":"3","article-title":"Effects of cyclosporine on adrenocortical stress response of Wistar rats","volume":"60","author":"Hirano","year":"1988","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"2025092123520898500_lvaf182-B163","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pbb.2014.09.006","article-title":"Short-term treatment with the calcineurin inhibitor cyclosporine A decreases HPA axis activity and plasma noradrenaline levels in healthy male volunteers","volume":"126","author":"Albring","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"2025092123520898500_lvaf182-B164","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/biology10080709","article-title":"Tacrolimus-based immunosuppressive therapy influences sex hormone profile in renal-transplant recipients\u2014a research study","volume":"10","author":"Szypulska-Koziarska","year":"2021","journal-title":"Biology (Basel)"},{"issue":"3","key":"2025092123520898500_lvaf182-B165","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00007890-199309000-00020","article-title":"Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments\u2013prednisolone and azathioprine versus prednisolone and cyclosporine","volume":"56","author":"Oka","year":"1993","journal-title":"Transplantation"},{"issue":"1-3","key":"2025092123520898500_lvaf182-B166","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3727\/215517912(639423","article-title":"Higher sensitivity of peripheral blood lymphocytes to endogenous glucocorticoid in renal transplant recipients treated with tacrolimus, as compared to those treated with cyclosporine","volume":"3","author":"Muhetaer","year":"2012","journal-title":"Cell Med"},{"issue":"4","key":"2025092123520898500_lvaf182-B167","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.pbb.2008.05.017","article-title":"Immunosuppressant calcineurin inhibitors phase shift circadian rhythms and inhibit circadian responses to light","volume":"90","author":"Katz","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"2025092123520898500_lvaf182-B168","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12967-015-0420-5","article-title":"Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients","volume":"13","author":"Leyking","year":"2015","journal-title":"J Transl Med"},{"issue":"3","key":"2025092123520898500_lvaf182-B169","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1600-079X.2006.00368.x","article-title":"Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated","volume":"41","author":"Rezzani","year":"2006","journal-title":"J Pineal Res"},{"issue":"12","key":"2025092123520898500_lvaf182-B170","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1097\/TP.0b013e3181c1e042","article-title":"Maximizing growth in children after renal transplantation","volume":"88","author":"Cochat","year":"2009","journal-title":"Transplantation"},{"issue":"4","key":"2025092123520898500_lvaf182-B171","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1600-6143.2010.03047.x","article-title":"A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study","volume":"10","author":"Grenda","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"2025092123520898500_lvaf182-B172","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/tp.0000000000001320","article-title":"Corticosteroid use and growth after pediatric solid organ transplantation: a systematic review and meta-analysis","volume":"101","author":"Tsampalieros","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"2025092123520898500_lvaf182-B173","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1046\/j.1523-1755.2002.00489.x","article-title":"Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS","volume":"62","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"issue":"5","key":"2025092123520898500_lvaf182-B174","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/clinpract14050156","article-title":"Management of early post-transplant hyperglycemia by dedicated endocrine care improves glycemic outcomes","volume":"14","author":"Kaplan","year":"2024","journal-title":"Clin Pract"},{"issue":"2","key":"2025092123520898500_lvaf182-B175","doi-asserted-by":"publisher","first-page":"e001796","DOI":"10.1136\/bmjoq-2021-001796","article-title":"Reducing hyperglycaemia post-kidney and liver transplant: a quality improvement initiative","volume":"11","author":"Clemens","year":"2022","journal-title":"BMJ Open Qual"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf182\/64259717\/lvaf182.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/3\/R1\/64259717\/lvaf182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/3\/R1\/64259717\/lvaf182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T03:52:14Z","timestamp":1758513134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/3\/R1\/8253264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf182","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,29]]}}}